Chronic inflammation of digestive organs can increase the risk for developing cancer. A
multi-disciplinary approach to patients with these problems has led to early diagnosis and
effective treatment, leading to cure. Surveillance programs can now identify patients who
are on the verge of getting cancer so that they can be treated before cancer develops.
Here at the UW Division of Gastroenterology, we believe, along with our partners, the Fred
Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance, that we will dramatically
push forward the frontiers of scientific discovery and patient care in the next 10 years.
We will be able to detect GI cancers at their precursor stages and intervene so that they can be
prevented or cured. We will offer cutting-edge treatment for GI cancers, resulting in superior
outcomes.